Immunofluorescence Assay Market: Global Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Immunofluorescence Assay Market: By Products (Antibodies, Reagents, Kits, Instruments, Consumables and Accessories), By Type (Indirect Immunofluorescence, Direct Immunofluorescence), By Disease (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Other Diseases), By End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Hospitals & Diagnostic Centers) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

1. Executive Summary
2. Global Immunofluorescence Assay Market Introduction
2.1. Global Immunofluorescence Assay Market – Taxonomy
2.2. Global Immunofluorescence Assay Market –Definitions
2.2.1. By Products
2.2.2. By Type
2.2.3. By Disease
2.2.4. By End User
2.2.5. By Region
3. Global Immunofluorescence Assay Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Immunofluorescence Assay Market Dynamic Factors – Impact Analysis
3.6. Global Immunofluorescence Assay Market – Competition Landscape
4. Global Immunofluorescence Assay Market Analysis, 2017-2021 and Forecast, 2022-2028
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Immunofluorescence Assay Market, By Drug Class, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Antibodies
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Reagents
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Kits
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Instruments
5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Consumables and Accessories
5.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. Global Immunofluorescence Assay Market, By Psoriasis Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. Indirect Immunofluorescence
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Direct Immunofluorescence
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. Global Immunofluorescence Assay Market, By Route of Administration, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Cancer
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Infectious Diseases
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Cardiovascular Diseases
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Autoimmune Diseases
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Other Diseases
7.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
8. Global Immunofluorescence Assay Market, By Distribution Channel, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. Academic & Research Institutes
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Pharmaceutical & Biotechnology Companies
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Contract Research Organizations
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Hospitals & Diagnostic Centers
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
9. Global Immunofluorescence Assay Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Immunofluorescence Assay Market – Opportunity Analysis Index, By Products, By Type, By Disease, By End User, and Region, 2022-2028
10. North America Immunofluorescence Assay Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. Products Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Antibodies
10.1.2. Reagents
10.1.3. Kits
10.1.4. Instruments
10.1.5. Consumables and Accessories
10.2. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Indirect Immunofluorescence
10.2.2. Direct Immunofluorescence
10.3. Disease Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Cancer
10.3.2. Infectious Diseases
10.3.3. Cardiovascular Diseases
10.3.4. Autoimmune Diseases
10.3.5. Other Diseases
10.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Academic & Research Institutes
10.4.2. Pharmaceutical & Biotechnology Companies
10.4.3. Contract Research Organizations
10.4.4. Hospitals & Diagnostic Centers
10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Immunofluorescence Assay Market – Opportunity Analysis Index, By Products, By Type, By Disease, By End User, and Country, 2022-2028
10.7. North America Immunofluorescence Assay Market Dynamics – Trends
11. Europe Immunofluorescence Assay Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. Products Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Antibodies
11.1.2. Reagents
11.1.3. Kits
11.1.4. Instruments
11.1.5. Consumables and Accessories
11.2. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Indirect Immunofluorescence
11.2.2. Direct Immunofluorescence
11.3. Disease Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Cancer
11.3.2. Infectious Diseases
11.3.3. Cardiovascular Diseases
11.3.4. Autoimmune Diseases
11.3.5. Other Diseases
11.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Academic & Research Institutes
11.4.2. Pharmaceutical & Biotechnology Companies
11.4.3. Contract Research Organizations
11.4.4. Hospitals & Diagnostic Centers
11.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Rest of Europe
11.6. Europe Immunofluorescence Assay Market – Opportunity Analysis Index, By Products, By Type, By Disease, By End User, and Country, 2022-2028
11.7. Europe Immunofluorescence Assay Market Dynamics – Trends
12. Asia-Pacific Immunofluorescence Assay Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. Products Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Antibodies
12.1.2. Reagents
12.1.3. Kits
12.1.4. Instruments
12.1.5. Consumables and Accessories
12.2. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Indirect Immunofluorescence
12.2.2. Direct Immunofluorescence
12.3. Disease Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Cancer
12.3.2. Infectious Diseases
12.3.3. Cardiovascular Diseases
12.3.4. Autoimmune Diseases
12.3.5. Other Diseases
12.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Academic & Research Institutes
12.4.2. Pharmaceutical & Biotechnology Companies
12.4.3. Contract Research Organizations
12.4.4. Hospitals & Diagnostic Centers
12.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Immunofluorescence Assay Market – Opportunity Analysis Index, By Products, By Type, By Disease, By End User, and Country, 2022-2028
12.7. Asia-Pacific Immunofluorescence Assay Market Dynamics – Trends
13. Latin America Immunofluorescence Assay Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. Products Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Antibodies
13.1.2. Reagents
13.1.3. Kits
13.1.4. Instruments
13.1.5. Consumables and Accessories
13.2. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Indirect Immunofluorescence
13.2.2. Direct Immunofluorescence
13.3. Disease Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Cancer
13.3.2. Infectious Diseases
13.3.3. Cardiovascular Diseases
13.3.4. Autoimmune Diseases
13.3.5. Other Diseases
13.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Academic & Research Institutes
13.4.2. Pharmaceutical & Biotechnology Companies
13.4.3. Contract Research Organizations
13.4.4. Hospitals & Diagnostic Centers
13.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Immunofluorescence Assay Market – Opportunity Analysis Index, By Products, By Type, By Disease, By End User, and Country, 2022-2028
13.7. Latin America Immunofluorescence Assay Market Dynamics – Trends
14. Middle East and Africa Immunofluorescence Assay Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
14.1. Products Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Antibodies
14.1.2. Reagents
14.1.3. Kits
14.1.4. Instruments
14.1.5. Consumables and Accessories
14.2. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Indirect Immunofluorescence
14.2.2. Direct Immunofluorescence
14.3. Disease Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Cancer
14.3.2. Infectious Diseases
14.3.3. Cardiovascular Diseases
14.3.4. Autoimmune Diseases
14.3.5. Other Diseases
14.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Academic & Research Institutes
14.4.2. Pharmaceutical & Biotechnology Companies
14.4.3. Contract Research Organizations
14.4.4. Hospitals & Diagnostic Centers
14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf CoEnd User Council (GCC) Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. MEA Immunofluorescence Assay Market – Opportunity Analysis Index, By Products, By Type, By Disease, By End User, and Country, 2022-2028
14.7. MEA Immunofluorescence Assay Market Dynamics – Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Key Products, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Thermo Fisher Scientific, Inc. (US)
15.2.2. Abcam plc (UK)
15.2.3. Bio-Rad Laboratories, Inc. (US)
15.2.4. PerkinElmer Inc. (US)
15.2.5. Merck KGaA (Germany)
15.2.6. Werfen Company (Spain)
15.2.7. Cell Signaling Technology, Inc. (US)
15.2.8. MEDIPAN GmbH (Germany)
15.2.9. Sino Biological, Inc. (China)
15.2.10. Danaher Corporation (US)
15.2.11. Maravai LifeSciences (US)
15.2.12. Enzo Biochem, Inc. (US)
16. Research Methodology
17. Key Assumptions and Acronyms

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Company Profile

  • Thermo Fisher Scientific, Inc. (US)
  • Abcam plc (UK)
  • Bio-Rad Laboratories, Inc. (US)
  • PerkinElmer Inc. (US)
  • Merck KGaA (Germany)
  • Werfen Company (Spain)
  • Cell Signaling Technology, Inc. (US)
  • MEDIPAN GmbH (Germany)
  • Sino Biological, Inc. (China)
  • Danaher Corporation (US)
  • Maravai LifeSciences (US)
  • Enzo Biochem, Inc. (US)

Description

1. Executive Summary
2. Global Immunofluorescence Assay Market Introduction
2.1. Global Immunofluorescence Assay Market – Taxonomy
2.2. Global Immunofluorescence Assay Market –Definitions
2.2.1. By Products
2.2.2. By Type
2.2.3. By Disease
2.2.4. By End User
2.2.5. By Region
3. Global Immunofluorescence Assay Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Immunofluorescence Assay Market Dynamic Factors – Impact Analysis
3.6. Global Immunofluorescence Assay Market – Competition Landscape
4. Global Immunofluorescence Assay Market Analysis, 2017-2021 and Forecast, 2022-2028
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Immunofluorescence Assay Market, By Drug Class, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Antibodies
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Reagents
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Kits
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Instruments
5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Consumables and Accessories
5.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. Global Immunofluorescence Assay Market, By Psoriasis Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. Indirect Immunofluorescence
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Direct Immunofluorescence
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. Global Immunofluorescence Assay Market, By Route of Administration, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Cancer
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Infectious Diseases
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Cardiovascular Diseases
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Autoimmune Diseases
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Other Diseases
7.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
8. Global Immunofluorescence Assay Market, By Distribution Channel, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. Academic & Research Institutes
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Pharmaceutical & Biotechnology Companies
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Contract Research Organizations
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Hospitals & Diagnostic Centers
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
9. Global Immunofluorescence Assay Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Immunofluorescence Assay Market – Opportunity Analysis Index, By Products, By Type, By Disease, By End User, and Region, 2022-2028
10. North America Immunofluorescence Assay Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. Products Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Antibodies
10.1.2. Reagents
10.1.3. Kits
10.1.4. Instruments
10.1.5. Consumables and Accessories
10.2. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Indirect Immunofluorescence
10.2.2. Direct Immunofluorescence
10.3. Disease Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Cancer
10.3.2. Infectious Diseases
10.3.3. Cardiovascular Diseases
10.3.4. Autoimmune Diseases
10.3.5. Other Diseases
10.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Academic & Research Institutes
10.4.2. Pharmaceutical & Biotechnology Companies
10.4.3. Contract Research Organizations
10.4.4. Hospitals & Diagnostic Centers
10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Immunofluorescence Assay Market – Opportunity Analysis Index, By Products, By Type, By Disease, By End User, and Country, 2022-2028
10.7. North America Immunofluorescence Assay Market Dynamics – Trends
11. Europe Immunofluorescence Assay Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. Products Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Antibodies
11.1.2. Reagents
11.1.3. Kits
11.1.4. Instruments
11.1.5. Consumables and Accessories
11.2. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Indirect Immunofluorescence
11.2.2. Direct Immunofluorescence
11.3. Disease Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Cancer
11.3.2. Infectious Diseases
11.3.3. Cardiovascular Diseases
11.3.4. Autoimmune Diseases
11.3.5. Other Diseases
11.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Academic & Research Institutes
11.4.2. Pharmaceutical & Biotechnology Companies
11.4.3. Contract Research Organizations
11.4.4. Hospitals & Diagnostic Centers
11.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Rest of Europe
11.6. Europe Immunofluorescence Assay Market – Opportunity Analysis Index, By Products, By Type, By Disease, By End User, and Country, 2022-2028
11.7. Europe Immunofluorescence Assay Market Dynamics – Trends
12. Asia-Pacific Immunofluorescence Assay Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. Products Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Antibodies
12.1.2. Reagents
12.1.3. Kits
12.1.4. Instruments
12.1.5. Consumables and Accessories
12.2. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Indirect Immunofluorescence
12.2.2. Direct Immunofluorescence
12.3. Disease Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Cancer
12.3.2. Infectious Diseases
12.3.3. Cardiovascular Diseases
12.3.4. Autoimmune Diseases
12.3.5. Other Diseases
12.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Academic & Research Institutes
12.4.2. Pharmaceutical & Biotechnology Companies
12.4.3. Contract Research Organizations
12.4.4. Hospitals & Diagnostic Centers
12.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Immunofluorescence Assay Market – Opportunity Analysis Index, By Products, By Type, By Disease, By End User, and Country, 2022-2028
12.7. Asia-Pacific Immunofluorescence Assay Market Dynamics – Trends
13. Latin America Immunofluorescence Assay Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. Products Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Antibodies
13.1.2. Reagents
13.1.3. Kits
13.1.4. Instruments
13.1.5. Consumables and Accessories
13.2. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Indirect Immunofluorescence
13.2.2. Direct Immunofluorescence
13.3. Disease Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Cancer
13.3.2. Infectious Diseases
13.3.3. Cardiovascular Diseases
13.3.4. Autoimmune Diseases
13.3.5. Other Diseases
13.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Academic & Research Institutes
13.4.2. Pharmaceutical & Biotechnology Companies
13.4.3. Contract Research Organizations
13.4.4. Hospitals & Diagnostic Centers
13.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Immunofluorescence Assay Market – Opportunity Analysis Index, By Products, By Type, By Disease, By End User, and Country, 2022-2028
13.7. Latin America Immunofluorescence Assay Market Dynamics – Trends
14. Middle East and Africa Immunofluorescence Assay Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
14.1. Products Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Antibodies
14.1.2. Reagents
14.1.3. Kits
14.1.4. Instruments
14.1.5. Consumables and Accessories
14.2. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Indirect Immunofluorescence
14.2.2. Direct Immunofluorescence
14.3. Disease Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Cancer
14.3.2. Infectious Diseases
14.3.3. Cardiovascular Diseases
14.3.4. Autoimmune Diseases
14.3.5. Other Diseases
14.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Academic & Research Institutes
14.4.2. Pharmaceutical & Biotechnology Companies
14.4.3. Contract Research Organizations
14.4.4. Hospitals & Diagnostic Centers
14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf CoEnd User Council (GCC) Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. MEA Immunofluorescence Assay Market – Opportunity Analysis Index, By Products, By Type, By Disease, By End User, and Country, 2022-2028
14.7. MEA Immunofluorescence Assay Market Dynamics – Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Key Products, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Thermo Fisher Scientific, Inc. (US)
15.2.2. Abcam plc (UK)
15.2.3. Bio-Rad Laboratories, Inc. (US)
15.2.4. PerkinElmer Inc. (US)
15.2.5. Merck KGaA (Germany)
15.2.6. Werfen Company (Spain)
15.2.7. Cell Signaling Technology, Inc. (US)
15.2.8. MEDIPAN GmbH (Germany)
15.2.9. Sino Biological, Inc. (China)
15.2.10. Danaher Corporation (US)
15.2.11. Maravai LifeSciences (US)
15.2.12. Enzo Biochem, Inc. (US)
16. Research Methodology
17. Key Assumptions and Acronyms

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX